|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,203.81 MXN | -0.28% |
|
+4.09% | -0.83% |
| 06-25 | Major deals involving US drugmakers and biotechs over the past decade | RE |
| 06-25 | Gilead Says FDA Approves Trodelvy for First-Line Treatment of Advanced Triple-Negative Breast Cancer | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 159B | - | ||||
| 1,077B | |||||
| 613B | |||||
| 448B | |||||
| 332B | |||||
| 293B |
Select your edition
All financial news and data tailored to specific country editions
